Up next

Autoplay

Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival

2 Views • 07/10/23
Share
Embed
administrator
administrator
Subscribers
0

The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay